Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention

Gerald Chi; Megan K. Yee; Arzu Kalaycı; Mathieu Kernéis; Fahad Alkhalfan; Roxana Mehran; Christoph Bode; Jonathan L. Halperin; Freek W.A. Verheugt; Peter Wildgoose; Martin van Eickels; Professor Gregory Lip; Marc Cohen; Eric D. Peterson; Keith A.A. Fox; C. Michael Gibson

doi:10.1007/s11239-018-1703-5

Back

Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention

Article 2018 en

Related publications

Article2020

Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention

Jiesuck Park, Eue-Keun Choi, Kyungdo Han, Bongseong Kim, You‐Jung Choi, So-Ryoung Lee, Jeehoon Kang, Myung‐Jin Cha, Kyung Woo Park, Seil Oh, Professor Gregory Lip

Article2022

Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention

Jiesuck Park, Jin‐Hyung Jung, Eue-Keun Choi, Seung‐Woo Lee, Soonil Kwon, So-Ryoung Lee, Jeehoon Kang, Kyungdo Han, Kyung Woo Park, Seil Oh, Professor Gregory Lip

Article2020

Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting

Monika Kozieł, Tatjana Potpara, Professor Gregory Lip

Article2024

Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention

Marco Valgimigli, Felice Gragnano, Mattia Branca, Anna Franzone, Bruno R. da Costa, Usman Baber, Takeshi Kimura, Yangsoo Jang, Joo‐Yong Hahn, Qiang Zhao, Stephan Windecker, C. Michael Gibson, Hirotoshi Watanabe, Byeong‐Keuk Kim, Young Bin Song, Yunpeng Zhu, Pascal Vranckx, Shamir R. Mehta, Giuseppe Andò, Sung‐Jin Hong, Hyeon‐Cheol Gwon, Patrick W. Serruys, George Dangas,

Article2020

Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome and / or undergoing percutaneous coronary intervention

M Mihajlović, M Marinković, Monika Kozieł, Nebojša Mujović, Professor Gregory Lip, Tatjana Potpara

Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention

Discussion(0)

Related publications

Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention

Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention

Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting

Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention

Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome and / or undergoing percutaneous coronary intervention